Valrubicin
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Valrubicin, covering 2014-10-22 to 2016-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma [Phase 1]